HIGHLIGHTS
- who: Stephen B Waters and collaborators from the Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, IL, USA University of Illinois College of Medicine, Chicago, IL, USA have published the research: KIF13B-mediated VEGFR2 trafficking is essential for vascular leakage and metastasis in vivo, in the Journal: (JOURNAL)
- what: This study showed that deletion of KIF13B in EC inhibited both VEGF-A-induced angiogenesis and vascular permeability. Nonetheless, this study showed that targeting KIF13B-mediated VEGFR2 trafficking to the EC plasmalemma may be a potential anti-angiogenesis and anti-metastatic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.